Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | Nov 22, 2024 | 5.80 | -0.85 |
Novabay Pharmaceuticals | B9P | Nov 22, 2024 | 2.80 | 0.00 |
Novacyt | NYZ | Nov 22, 2024 | 0.55 | -0.72 |
Novagold Resources Inc. | NGR | Nov 22, 2024 | 3.42 | +1.97 |
Novanta Inc. - | 1GSN | Nov 22, 2024 | 157.00 | -0.63 |
Novartis AG | NOTA | Nov 22, 2024 | 101.00 | +2.43 |
Novavax, Inc. | NVV1 | Nov 22, 2024 | 8.20 | +3.59 |
Novem Group S.A. | NVM | Nov 22, 2024 | 5.64 | +3.30 |
NOVINA S.A. E ZY 1,16 | T36 | Nov 22, 2024 | 0.23 | +4.85 |
Novo Nordisk A/S | NOVA | Nov 22, 2024 | 100.50 | +3.18 |
Novo Resources Corp | 1NOR | Nov 22, 2024 | 0.05 | 0.00 |
NovoCure Limited - Ordinary Shares | 038 | Nov 22, 2024 | 16.18 | +1.25 |
NOVONIX ADR | GC30 | Nov 22, 2024 | 1.73 | -2.26 |
Novonix Limited | GC3 | Nov 22, 2024 | 0.45 | -1.85 |
NOVOTEK AB B SK-,25 | Z9D | Nov 22, 2024 | 5.82 | 0.00 |
Novozymes AS | NZM | Nov 22, 2024 | 54.00 | 0.00 |
Novozymes B | NZM2 | Nov 22, 2024 | 56.76 | +4.07 |
Novra Technologies Inc. | 7CV | Nov 22, 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | Nov 22, 2024 | 0.39 | -0.52 |
NOW Inc. | 11N | Nov 22, 2024 | 13.60 | +1.49 |
NP3 Fastigheter | N33 | Nov 22, 2024 | 21.25 | +5.72 |
NPC Inc | 59N | Nov 22, 2024 | 5.65 | +3.67 |
NRC Group | 8NR | Nov 22, 2024 | 0.29 | +1.77 |
NRG Energy Inc. | NRA | Nov 22, 2024 | 92.14 | +3.16 |
NRJ Group | NR8 | Nov 22, 2024 | 6.98 | -0.57 |
NRW Holdings Limited | 3NR | Nov 22, 2024 | 2.36 | +0.85 |
Ns United Kaiun Kaisha, Ltd. | 8WN | Nov 22, 2024 | 25.40 | +3.25 |
NSE SA | 7YM | Nov 22, 2024 | 28.00 | 0.00 |
NSI N.V. | N4RN | Nov 22, 2024 | 19.56 | +0.20 |
NSJ Gold Corp | 9PZ | Nov 22, 2024 | 0.01 | +4.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.